RxDoctor Payments Data

Samantha Ivy, APRN

Family · Savannah, TNNPI 1992401541

Payments from drug & device makers

$482in general payments, 2019–2025

Across 21 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$156
  • Cvrx, Inc.$81
  • Otsuka America Pharmaceutical, Inc.$51
  • Pfizer$46
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$32
  • Novo Nordisk$32
  • plus $83 from 4 others

What the payments were for

  • Food & beverage$482100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$482 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$16,652
Medicare patients
143
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$56,367
MounjaroTirzepatide34$35,601
FarxigaDapagliflozin Propanediol47$31,807
VraylarCariprazine Hcl16$22,769
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$14,573
EliquisApixaban20$13,971
LinzessLinaclotide15$7,978
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,026
Dexlansoprazole DrDexlansoprazole16$2,831
Esomeprazole Magnesium45$2,233
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$1,880
LantusInsulin Glargine,hum.Rec.Anlog11$1,472
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,365
Albuterol Sulfate HfaAlbuterol Sulfate72$1,305
Gabapentin99$1,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$32$56,36749 claims
AstraZenecaFarxiga, Breztri Aerosphere$156$46,38068 claims
Lilly USA, LLCMounjaro$20$35,60134 claims
AbbVieVraylar, Linzess$23$30,74731 claims
PfizerEliquis$46$13,97120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Savannah

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →